A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder
Clinical trial NCT03924323 · COMPLETED
Trial details
- NCT number
- NCT03924323
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2021-09-20
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.